Kevin Litchfield Selected Research

Kevin Litchfield Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 01/2016
9	Melanoma (Melanoma, Malignant) 11/2023 - 05/2017
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2019
5	Lung Neoplasms (Lung Cancer) 04/2024 - 10/2019
4	Adenocarcinoma of Lung 04/2024 - 05/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 11/2021
3	Chromosomal Instability (Chromosome Stability) 01/2023 - 10/2019
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 05/2017
2	Bites and Stings (Sting) 01/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 05/2017
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 05/2017
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Trisomy (Trisomies) 01/2023
1	Aneuploidy (Aneuploid) 01/2023
1	Necrosis 01/2023
1	Residual Neoplasm 01/2023
1	Inflammation (Inflammations) 01/2021
1	Carcinogenesis 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 05/2017
1	Neuroblastoma 05/2017
1	Glioma (Gliomas) 05/2017
1	Endometrial Neoplasms (Endometrial Cancer) 05/2017
1	Carcinoma (Carcinomatosis) 11/2016
1	Teratoma (Teratoid Tumor) 11/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2016
1	Testicular Germ Cell Tumor 11/2014

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2019
6	RNA (Ribonucleic Acid)IBA 11/2023 - 10/2019
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2019
3	AntibodiesIBA 12/2023 - 01/2018
3	cyclopropapyrroloindoleIBA 11/2023 - 01/2020
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2024 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 12/2023 - 05/2023
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2014
2	AntigensIBA 01/2021 - 01/2021
1	Vitamin D FDA LinkGeneric 04/2024
1	Dinoprostone (PGE2)FDA Link 04/2024
1	CTLA-4 AntigenIBA 12/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 05/2023
1	mepazineIBA 05/2023
1	Succinic Acid (Succinate)IBA 05/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	InterferonsIBA 01/2023
1	Interferon Receptors (Interferon Receptor)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Particulate MatterIBA 01/2023
1	Air Pollutants (Pollutants, Air)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	NivolumabIBA 11/2021
1	ChromatinIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Carisoprodol (Soma)FDA LinkGeneric 01/2021
1	UbiquitinIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 11/2020
1	PlatinumIBA 01/2020
1	SolutionsIBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2018
1	tremelimumabIBA 01/2018
1	IpilimumabIBA 01/2018
1	ORALIT (ORS)IBA 05/2017
1	GenieIBA 01/2017
1	Shelterin ComplexIBA 11/2016

Therapy/Procedure

14	Immunotherapy 04/2024 - 12/2019
11	Therapeutics 12/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 11/2016 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020